Related Experiment Video
Updated: Mar 24, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities
Camilla Lööv1, Clemens R Scherzer2, Bradley T Hyman3
1Departments of Neurology and Radiology, Massachusetts General Hospital and Center for NeuroDiscovery, Harvard Medical School, Boston, MA, USA.
Toxic oligomers of alpha-synuclein, not fibrillar forms, drive Parkinson's disease (PD) pathology. Extracellular vesicles (EVs) may spread these harmful oligomers, offering potential diagnostic biomarkers in patient plasma.
Area of Science:
- Neuroscience
- Biochemistry
- Biomarker Discovery
Background:
- Intraneuronal alpha-synuclein fibrils characterize Parkinson's disease (PD) and Lewy body disorders.
- Harmful alpha-synuclein oligomers, not insoluble fibrils, are implicated in neurotoxicity.
- Extracellular vesicles (EVs) may mediate the intercellular propagation of toxic alpha-synuclein species.
Purpose of the Study:
- Investigate the role of extracellular vesicles (EVs) in alpha-synuclein propagation in PD.
- Explore the potential of alpha-synuclein within EVs as diagnostic biomarkers for PD.
- Determine if specific alpha-synuclein oligomeric forms in EVs are superior biomarkers.
Main Methods:
- Analysis of alpha-synuclein within extracellular vesicles (EVs) isolated from patient plasma.
- Comparison of alpha-synuclein levels in L1CAM-positive vesicles between PD patients and healthy controls.
- Assessment of different alpha-synuclein aggregational states within EVs.
Main Results:
- Elevated levels of alpha-synuclein were detected in L1CAM-positive EVs from PD patients compared to controls.
- Evidence suggests that toxic prefibrillar alpha-synuclein oligomers may be more reflective of the disease process.
- Stringent EV isolation protocols are crucial to avoid contamination and accurately measure alpha-synuclein.
Conclusions:
- Extracellular vesicles (EVs) may play a role in the spread of Parkinson's disease pathology via alpha-synuclein transfer.
- Alpha-synuclein within specific EV populations in plasma shows promise as a potential diagnostic biomarker for PD.
- Targeting toxic alpha-synuclein oligomers in EVs could offer a more precise biomarker strategy for Parkinson's disease.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Lysosomal Hydrolases